SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Galectin Therapeutics Inc Unit Cons of 2 shs + 1 Wt
(NASDAQ : GALTU)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading GALTU News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.18%81.371.2%$819.56m
AMGNAmgen Inc.
-0.47%174.801.1%$460.83m
BIIBBiogen Inc.
-0.71%312.581.0%$441.76m
MDVNMedivation, Inc.
0.42%81.421.9%$436.64m
SRPTSarepta Therapeutics, Inc.
-5.15%57.8330.9%$408.21m
CELGCelgene Corporation
-1.03%109.430.8%$405.97m
REGNRegeneron Pharmaceuticals, Inc.
0.58%410.393.2%$302.11m
CPHDCepheid
0.00%52.504.7%$200.30m
ALXNAlexion Pharmaceuticals, Inc.
-4.84%127.222.3%$175.19m
CLVSClovis Oncology, Inc.
-3.18%37.1425.5%$166.98m
ILMNIllumina, Inc.
-0.01%179.333.4%$137.85m
VRTXVertex Pharmaceuticals Incorporated
-1.62%90.632.2%$121.43m
BMRNBioMarin Pharmaceutical Inc.
-0.05%97.403.8%$118.10m
TSROTESARO, Inc.
0.15%108.5915.9%$116.58m
INCYIncyte Corporation
-0.33%88.982.7%$107.31m

Company Profile

Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA.